Targeting the Negative Feedback of Adenosine‐A2AR Metabolic Pathway by a Tailored Nanoinhibitor for Photothermal Immunotherapy
2022 · Advanced Science · 58 citations
https://doi.org/10.1002/advs.202104182
D
Dailin Xu
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
11
Papers
532
Citations
7
h-index
7
i10-index
Dailin Xu is an academic researcher from Shanghai Skin Disease Hospital. The author has contributed to research in topics: Nanoplatforms for cancer theranostics & Nanoparticle-Based Drug Delivery & Cancer, Hypoxia, and Metabolism. The author has an h-index of 7, co-authored 10 publications.
Papers by this author
worksNanofactory for metabolic and chemodynamic therapy: pro-tumor lactate trapping and anti-tumor ROS transition
2021 · Journal of Nanobiotechnology · 53 citations
https://doi.org/10.1186/s12951-021-01169-9
Photosensitizer-Laden Neutrophils Are Controlled Remotely for Cancer Immunotherapy
2020 · Cell Reports · 12 citations
https://doi.org/10.1016/j.celrep.2020.108499
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat